Evidence map›Paper›PMID 20534572›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Single cell trapping and DNA damage analysis using microwell arrays.

David K Wood, David M Weingeist, Sangeeta N Bhatia, Bevin P Engelward

Open access · greenAbstract readValidation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 259 citations in OpenAlex.

  1. Article
  2. Article
  3. New Approach Methods in Genetic Toxicology.Environmental and molecular mutagenesis · 2026
    Article
  4. The Comet Assay in Human Biomonitoring.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Single-Cell Nucleus Extraction with Cellular Indexing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Transferability and Reproducibility of the HepaRG CometChip Assay.Environmental and molecular mutagenesis · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Double Digital Assay for Single Extracellular Vesicle and Single Molecule Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  12. Chemical Insights into Oxidative and Nitrative Modifications of DNA.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Sonic snares: Trapping microorganisms for deeper insights into swimming behavior and ciliary dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

David K WoodHarvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
David M Weingeist
Sangeeta N Bhatia
Bevin P Engelward
Massachusetts Institute of Technology · USHarvard–MIT Division of Health Sciences and Technology · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
TRAINING GRANTS IN ENVIROMENTAL TOXICOLOGYT32ES007020 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1985 to 2024
$13.1M
Comet-Chip: A High-Throughput DNA Damage Sensor for Enviornmental Health StudiesU01ES016045 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ENGELWARD, BEVIN P. · 2007 to 2010
$1.8M
Howard Hughes Medical InstituteNIEHS NIH HHS P30 ES002109NIEHS NIH HHS P30-ES002109NIEHS NIH HHS T32 ES007020NIEHS NIH HHS T32-ES07020-34NIEHS NIH HHS U01 ES016045NIEHS NIH HHS U01-ES016045
6 · The paper itself

Abstract

With a direct link to cancer, aging, and heritable diseases as well as a critical role in cancer treatment, the importance of DNA damage is well-established. The intense interest in DNA damage in applications ranging from epidemiology to drug development drives an urgent need for robust, high throughput, and inexpensive tools for objective, quantitative DNA damage analysis. We have developed a simple method for high throughput DNA damage measurements that provides information on multiple lesions and pathways. Our method utilizes single cells captured by gravity into a microwell array with DNA damage revealed morphologically by gel electrophoresis. Spatial encoding enables simultaneous assays of multiple experimental conditions performed in parallel with fully automated analysis. This method also enables novel functionalities, including multiplexed labeling for parallel single cell assays, as well as DNA damage measurement in cell aggregates. We have also developed 24- and 96-well versions, which are applicable to high throughput screening. Using this platform, we have quantified DNA repair capacities of individuals with different genetic backgrounds, and compared the efficacy of potential cancer chemotherapeutics as inhibitors of a critical DNA repair enzyme, human AP endonuclease. This platform enables high throughput assessment of multiple DNA repair pathways and subpathways in parallel, thus enabling new strategies for drug discovery, genotoxicity testing, and environmental health.

Indexed as

DNA DamageCell LineComet AssayDNA-(Apurinic or Apyrimidinic Site) LyaseDNA RepairEnzyme InhibitorsEquipment DesignHumansNeoplasmsOligonucleotide Array Sequence AnalysisAPEX1 protein, humanDNA-(Apurinic or Apyrimidinic Site) LyaseEnzyme Inhibitors

Identifiers

PMID20534572
PMCPMC2890454
OpenAlexW2140465521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.